Korean J Hematol.
2011 Sep;46(3):148-150. 10.5045/kjh.2011.46.3.148.
Engineered therapeutic antibodies with enhanced effector functions: Clinical application of the Potelligent(R) Technology
- Affiliations
-
- 1Department of Clinical Development, Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan.
- KMID: 2251994
- DOI: http://doi.org/10.5045/kjh.2011.46.3.148
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Effect of Prostaglandin and its Inhibitor on the Antibody - dependent Cellular Cytotoxicity Against Human Squamous Cell Carcinoma of the Head and Neck
- Affibody molecules as engineered protein drugs
- Engineered Extracellular Vesicles as a Targeted Delivery Platform for Precision Therapy
- Engineered T Cell Receptor for Cancer Immunotherapy
- Robot-assisted Therapy in Stroke Rehabilitation
